Video

Q&A With Stanley Fineman From Atlanta Allergy & Asthma: Guiding Doctors And Patients Through New Forms Of Immunotherapy For Allergy & Asthma Treatment

Author(s):

As new medications are approved for patients with allergies and asthma it becomes more important that doctors are able to provide them with the key information about these therapies and what it can mean for their overall care.

As new medications are approved for patients with allergies and asthma it becomes more important that doctors are able to provide them with the key information about these therapies and what it can mean for their overall care.

Stanley Fineman, MD, MBA, from Atlanta Allergy & Asthma discussed the best ways for doctors to approach the subject and what patients shuld know about the new sublingual immunotherapy options during the annual meeting of the American College of Allergy, Asthma, & Immunology (ACAAI) in San Antonio.

Fineman, a past president of the ACAAI also talked about a series of comic books written by physicians and peer reviewed by specialists like himself meant to help children better understand their condition in a fun and educational way.

Related Videos
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD
How to Manage Aspirin-Exacerbated Respiratory Disease
Physician, Patient, and Partner Perspectives on AERD with Mitchell Grayson, MD, Rhonda Nelson, and Wayne Nelson
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Monica Kraft, MD: Discussing Phase 3b Findings on Albuterol/Budesonide for Asthma
Developing Risk Assessment Tools for Viruses in School
What Do Patients Need to Learn About their Hypersensitivity Pneumonitis?
Allergies and Asthma During the School Year, with S. Christy Sadeameli, MD, and Juanita Mora, MD
Impact of the Nasal Epinephrine Spray for Patients with Severe Allergies, with Edwin H. Kim, MD
© 2025 MJH Life Sciences

All rights reserved.